Publications
Published in Top 10% journals in the field
The Development and Validation of Radiopharmaceuticals Targeting Bacterial Infection.
Journal of Nuclear Medicine.
2023,
ISSN: 0161-5505,
PMID: 37770110.
Identification of novel dithiocarbamate-copper complexes targeting p97/NPL4 pathway in cancer cells.
European Journal of Medicinal Chemistry.
2023,
261,
115790,
ISSN: 0223-5234 ,
PMID: 37690264,
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors.
Journal of Medicinal Chemistry.
2023,
66(14),
9577-9591,
ISSN: 0022-2623,
PMID: 37450644,
[68Ga]Ga-Ornibactin for Burkholderia cepacia complex Infection Imaging Using Positron Emission Tomography.
Journal of Medicinal Chemistry.
2023,
ISSN: 0022-2623,
PMID: 37252893,
Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET.
Cell Death and Differentiation.
2023,
ISSN: 1350-9047,
PMID: 37142656,